Novel strategies aim to separate GVHD from GVL effects in leukemia patients

This narrative review looks at novel therapeutic strategies for patients undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. The main goal is to separate the harmful effects of graft-versus-host disease from the beneficial graft-versus-leukemia effects. The authors discuss various approaches, including selective modulation of T-cell trafficking, enhancement of tissue tolerance, and cellular therapies. They also mention methods to restore leukemia immunogenicity and eliminate leukemia stem cells. These strategies aim to reshape the tumor immune microenvironment and modulate T-cell exhaustion. The review does not report specific safety concerns, adverse events, or discontinuations related to these interventions. Because this is a narrative review, it summarizes existing ideas rather than reporting new trial data. Readers should understand that these are potential directions for future research. The main reason to be careful is that no specific outcomes or safety data are provided in this text. This article offers a general overview of concepts rather than concrete evidence for immediate clinical use.